We are Sorry, This Page doesn't Exist
AstraZeneca"s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement. read more.....»»
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data. read more.....»»
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. read more.....»»
Sutro Biopharma ovarian cancer data "impressive," says Piper Sandler
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
I-Mab Showcases Early Data On Uliledlimab/Atezolizumab Combo In Advanced Cancer Settings
read more.....»»
In major cell therapy manufacturing deal, UCSF, biotech tools leader Thermo Fisher go small to go big
The new cell therapy manufacturing facility, which will open early next year, will be able to deliver highly specialized cell therapies to patients in clinical trials at UCSF's women's, children's and cancer hospitals complex across Mariposa Street......»»
Biotech developer trains sights on Seattle"s homelessness crisis
Alexandria Real Estate is currently working through feasibility research for a proposal envisioned to deliver a data-driven treatment campus much like one it backed in Ohio......»»
INSIDE BIOTECH: See the drug companies that are growing the fastest and pay workers the most
Insider analyzed data from more than 150 .....»»
Bristol Meyers Squibb pays $200M for Lexington biotech"s cancer antibody
Agenus Inc. has signed its largest licensing deal ever for a tumor-fighting antibody that is still in preclinical development......»»
Mustang Bio EHA abstract data "looks promising," says Cantor Fitzgerald
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment
Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»
William Blair views safety data from Krystal Biotech positively
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. read more.....»»
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»
ADVAXIS MAKING BOLD STEPS IN NEW CANCER STUDIES AND AGREEMENT WITH COLUMBIA UNIVERSITY
Advaxis, Inc. (NASDAQ: ADXS), CEO Ken Berlin presented at the Benzinga Biotech Small-Cap Conference on March 24, 2021. read more.....»»
Evaxion Biotech presents paper on deep data on immune complex stability
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
iCAD presented new data for ProFound AI breast cancer detection
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Purple Biotech presents additional data for NT219 at AACR 2021 meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Silver lining: Pandemic triggers booms in D.C. region’s biotech, data center industries
Montgomery, Loudoun and Prince William counties welcome billions of dollars in investments......»»
: FibroGen stock drops as biotech clarifies data classification in study data
FibroGen Inc. FGEN shares fell in .....»»